ADMA FY 2011 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$26,464

Net Income

-$26,460

EPS (Diluted)

$-0.00

Cash Flow

Operating Cash Flow

-$29,000

Free Cash Flow

-$29,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$8,079

Total Liabilities

$5,306

Stockholders' Equity

$2,773

Cash & Equivalents

$8,079

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$26,464	-$20,530	-28.9%
Net Income	-$26,460	-$20,526	-28.9%